125 related articles for article (PubMed ID: 16264399)
1. Metallothionein stroma reaction in tumor adjacent healthy tissue in head and neck squamous cell carcinoma and breast adenocarcinoma.
Dutsch-Wicherek M; Popiela TJ; Klimek M; Rudnicka-Sosin L; Wicherek L; Oudinet JP; Skladzien J; Tomaszewska R
Neuro Endocrinol Lett; 2005 Oct; 26(5):567-74. PubMed ID: 16264399
[TBL] [Abstract][Full Text] [Related]
2. The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity.
Popiela TJ; Rudnicka-Sosin L; Dutsch-Wicherek M; Klimek M; Basta P; Galazka K; Wicherek L
Neuro Endocrinol Lett; 2006 Dec; 27(6):786-94. PubMed ID: 17187007
[TBL] [Abstract][Full Text] [Related]
3. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
[TBL] [Abstract][Full Text] [Related]
4. Analysis of metallothionein and vimentin immunoreactivity in pharyngeal squamous cell carcinoma and its microenvironment.
Dutsch-Wicherek M; Lazar A; Tomaszewska R; Kazmierczak W; Wicherek L
Cell Tissue Res; 2013 May; 352(2):341-9. PubMed ID: 23397427
[TBL] [Abstract][Full Text] [Related]
5. The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease.
Walentowicz-Sadlecka M; Koper A; Krystyna G; Koper K; Basta P; Mach P; Skret-Magierlo J; Dutsch-Wicherek M; Sikora J; Grabiec M; Kazmierczak W; Wicherek L
Am J Reprod Immunol; 2013 Sep; 70(3):253-61. PubMed ID: 23590599
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein immunoreactivity in head and neck carcinomas; special reference to clinical behaviors and chemotherapy responses.
Muramatsu Y; Hasegawa Y; Fukano H; Ogawa T; Namuba M; Mouri K; Fujimoto Y; Matsuura H; Takai Y; Mori M
Anticancer Res; 2000; 20(1A):257-64. PubMed ID: 10769664
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Ro JY; Hong WK; Hittelman WN
Cancer Res; 1994 Jun; 54(12):3153-9. PubMed ID: 8205534
[TBL] [Abstract][Full Text] [Related]
9. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness.
Culhaci N; Metin K; Copcu E; Dikicioglu E
BMC Cancer; 2004 Aug; 4():42. PubMed ID: 15291964
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases.
Koene G; Mulder A; van der Ven K; Eijsink C; Franke M; Slootweg P; Claas F; Tilanus M
Hum Immunol; 2006 Sep; 67(9):692-9. PubMed ID: 17002899
[TBL] [Abstract][Full Text] [Related]
12. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
Sinha UK; Mazhar K; Chinn SB; Dhillon VK; Liu L; Masood R; Rice DH; Gill PS
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1053-9. PubMed ID: 17043250
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
[TBL] [Abstract][Full Text] [Related]
14. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
[TBL] [Abstract][Full Text] [Related]
16. Potential biomarkers for head and neck squamous cell carcinoma.
Brown JJ; Xu H; Nishitani J; Mohammed H; Osborne R; Teklehaimanot S; Gill G; Liu X
Laryngoscope; 2003 Mar; 113(3):393-400. PubMed ID: 12616185
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
[TBL] [Abstract][Full Text] [Related]
18. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium.
Irjala H; Alanen K; Grénman R; Heikkilä P; Joensuu H; Jalkanen S
Cancer Res; 2003 Aug; 63(15):4671-6. PubMed ID: 12907648
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers.
Tacha D; Bremer R; Haas T; Qi W
Arch Pathol Lab Med; 2014 Oct; 138(10):1358-64. PubMed ID: 24528495
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas.
Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S
Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]